PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy as First-line Treatment for Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis.

J Immunother · 2022 · PMC9087869 · PMID 35467579

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

a near-significant trendP =0.05actually significant

In terms of grade 3 or higher TRAEs, there was no significant difference, but there was a near-significant trend (OR=1.24; 95% CI: 1.00–1.55, P =0.05) (Fig. 5 B).

also in 290 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.